| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/27/2013 | WO2013094992A2 Use of growth factor for regenerating damaged periodontal tissue and pulp tissue of extracted tooth, composition containing said growth factor as active ingredient, and kit for tissue regeneration |
| 06/27/2013 | WO2013093849A1 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
| 06/27/2013 | WO2013093039A1 Peptides targeting receptor activator of nuclear factor -kappa b (rank) and their applications |
| 06/27/2013 | WO2013092753A1 Indole derivatives inhibitors of enzyme lactate dehydrogenase (ldh) |
| 06/27/2013 | WO2013092574A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | US20130165458 Quinazoline compounds as kinase inhibitors |
| 06/27/2013 | US20130165428 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/27/2013 | US20130164303 Combination preparation including a cytokine antagonist |
| 06/27/2013 | US20130164292 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors |
| 06/27/2013 | US20130164286 Fc FUSION PROTEINS |
| 06/27/2013 | DE102010014260A1 Treating e.g. cancer and multiple sclerosis in humans or animals, comprises placing patient into artificial coma, and treating tumors, abnormal cells and/or disease caused by optimized protein-free or very low-protein extreme fasting cure |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2856964A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/26/2013 | EP2606905A1 Peptides targeting Receptor activator of nuclear factor-kappa B (RANK) and their applications |
| 06/26/2013 | EP2606904A1 Medicine or food supplement for treating and/or preventing joint ailments |
| 06/26/2013 | EP2606896A1 Sterile emulsion containing hyaluronate and glucocorticoid, and use of such emulsion in the treatment of inflammatory joint disorders |
| 06/26/2013 | EP2606066A1 Antibodies that bind myostatin, compositions and methods |
| 06/26/2013 | EP2606044A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 06/26/2013 | EP2606042A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor |
| 06/26/2013 | EP2605771A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 06/26/2013 | CN1871343B Method and system for preparing stem cells from fat tissue |
| 06/26/2013 | CN103180316A Compounds that modulate intracellular calciu |
| 06/26/2013 | CN103180293A 23-yne-vitamin D3 derivative |
| 06/26/2013 | CN103179985A Antibodies that bind csf1r |
| 06/26/2013 | CN103173477A Method for stably expressing recombined human serum albumin and human parathyroid hormone (1-34)ab diad fusion protein by using saccharomyces cerevisiae |
| 06/26/2013 | CN103173459A Mouse-anti-human T cell antigen ZCH-2B8a monoclonal antibody variable region gene and use |
| 06/26/2013 | CN103172746A Tripolymer fc fusion proteins and use thereof |
| 06/26/2013 | CN103172743A Human Antibodies That Bind Cd22 And Uses Thereof |
| 06/26/2013 | CN103172699A 17beta-amino-11alpha-hydroxy-androsta-1,4-diene-3-ketone modified RGD tetrapeptide as well as synthesis and medical application thereof |
| 06/26/2013 | CN103172648A Tri-heterocyclic derivative, preparation method and application thereof |
| 06/26/2013 | CN103172631A Condensed pyrimidine derivative serving as transient receptor potential vanilla 3 (TRRV3) regulator |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103172573A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172572A Particulates of crth2 antagonist |
| 06/26/2013 | CN103172568A Cathepsin cysteine protease inhibitors |
| 06/26/2013 | CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof |
| 06/26/2013 | CN103169972A New application of statin compound as topical medicine for preventing and curing osteoporotic fracture |
| 06/26/2013 | CN103169966A Medicinal composition for treating systemic lupus erythematosus |
| 06/26/2013 | CN103169950A BMP-2 (Bone Morphogenetic Protein-2) sustained release microsphere and preparation method thereof |
| 06/26/2013 | CN103169938A Drug for treating scapulohumeral periarthritis |
| 06/26/2013 | CN103169936A Traditional Chinese medicine composition for treating bone disease, and preparation method and using method thereof |
| 06/26/2013 | CN103169933A Chinese herbal medicine compound preparation used for treating slipped disk, and preparation method thereof |
| 06/26/2013 | CN103169901A Traditional Chinese medicine composition for treating postoperative hematoma of knee joint |
| 06/26/2013 | CN103169900A Chinese herba preparation for treating gout |
| 06/26/2013 | CN103169899A Drug for treating hydrops articuli |
| 06/26/2013 | CN103169877A Traditional Chinese medicine for treating rheumatic arthritis |
| 06/26/2013 | CN103169876A Chinese medicament composition for treating arthralgia |
| 06/26/2013 | CN103169840A Drug for treating cervical spondylosis |
| 06/26/2013 | CN103169837A Composition for preventing osteoporosis |
| 06/26/2013 | CN103169835A Traditional Chinese medicine for treating osteoarticular diseases, and preparation method thereof |
| 06/26/2013 | CN103169830A External medicinal liquor for treating closed soft tissue injury |
| 06/26/2013 | CN103169827A Traditional Chinese medicine composite for curing multiple external injuries |
| 06/26/2013 | CN103169822A Synovitis hui-nationality ointment and preparation method thereof |
| 06/26/2013 | CN103169821A Tendon relaxing and collateral activating plaster and making method thereof |
| 06/26/2013 | CN103169805A Medicament for treating meniscus injury |
| 06/26/2013 | CN103169742A Application of elaeagnus conferta roxb |
| 06/26/2013 | CN103169735A Traditional Chinese medicine for treating rheumatic arthritis and rheumatoid arthritis |
| 06/26/2013 | CN103169731A Methods of generating, repairing and/or maintaining connective tissue in vivo |
| 06/26/2013 | CN103169710A Application of compounds containing thiadiazolo pyrimidone in treatment and prevention of osteoporosis |
| 06/26/2013 | CN103169709A Application of thiadiazolo pyrimidone compounds in treatment of hypercalcemia and tumor bone metastases |
| 06/26/2013 | CN103169708A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 06/26/2013 | CN103169686A Piroxicam-containing external transdermal absorbent and preparation method thereof |
| 06/26/2013 | CN103169092A L-asparaginic acid chelated calcium drinking water |
| 06/26/2013 | CN102614119B Method for sinomenine hydrochloride injection by using non-organic solvent |
| 06/26/2013 | CN102600113B Organic solvent-free preparation method of sinomenine hydrochloride cataplasm |
| 06/26/2013 | CN102552552B Traumatic injury plaster and preparation method thereof |
| 06/26/2013 | CN102430129B Bone morphogenetic protein-2/basic fibroblast growth factor (BMP-2/bFGF) double-gene chitosan nano-microcapsules and application thereof |
| 06/26/2013 | CN102370827B Chinese medicinal composition for preventing and treating osteoporosis and preparation method thereof |
| 06/26/2013 | CN102269752B Detection method for pharmaceutical composition preparation |
| 06/26/2013 | CN102188572B Traditional Chinese drug for treating bone trauma |
| 06/26/2013 | CN101918002B Methods and compositions for treating intervertebral disc herniations |
| 06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
| 06/25/2013 | US8470813 Thiazoline and oxazoline derivatives and their methods of use |
| 06/25/2013 | US8470370 Controlled release formulations |
| 06/25/2013 | US8470337 Therapeutic treatments using botulinum neurotoxin |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2542434C Combination of flupirtine and tolperisone or eperisone for the treatment of painful conditions |
| 06/25/2013 | CA2480217C G-type peptides to ameliorate atherosclerosis |
| 06/25/2013 | CA2380940C Substances and agents for positively influencing collagen |
| 06/20/2013 | WO2013089252A1 Modification of helper t cell-inducing polypeptide |
| 06/20/2013 | WO2013088449A1 Stable crystal form of febuxostat and process for the preparation thereof |
| 06/20/2013 | WO2013088440A1 Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders |
| 06/20/2013 | WO2013088191A1 Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3 |
| 06/20/2013 | WO2013087914A1 EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| 06/20/2013 | WO2013087913A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087912A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087911A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087725A1 Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3 |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/20/2013 | DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 06/19/2013 | EP2604601A1 Hetero ring compound |
| 06/19/2013 | EP2604259A1 LSD-1 enzyme inhibitors for inducing osteogenic differentiation |
| 06/19/2013 | EP2603236A1 Anti-syndecan-4 antibodies |
| 06/19/2013 | EP2603218A1 Quinolyl amines as kinase inhibitors |
| 06/19/2013 | CN103168039A Imidazopyridines syk inhibitors |